# Stanford Diabetes Research Center

> **NIH NIH P30** · STANFORD UNIVERSITY · 2023 · $1,967,401

## Abstract

CENTER OVERVIEW: PROJECT SUMMARY/ABSTRACT
The Stanford Diabetes Research Center (SDRC) embodies the culmination of a strategic plan by the Stanford
University School of Medicine to create a premier program founded on a base of superb, collaborative
investigators studying basic, clinical and translational problems in diabetes research. The SDRC mission is to
foster innovation, new knowledge, and training in diabetes-related research, leading to improved diagnosis,
treatment, and ultimately, prevention and cure of diabetes and its complications. Renewal of this P30
application will leverage diabetes research at Stanford University by providing crucial resources dedicated to
supporting investigations and enrichment activities focused on diabetes. Stanford has a strong tradition of
academic excellence, innovation, and clinical care, united in a true University on a single campus that fosters
interactions between scientists and clinicians from different disciplines. Stanford is in the heart of Silicon
Valley, an epicenter of innovation and calculated risk-taking, whose companies partner with SDRC faculty in
unique and growing collaborations to advance diabetes research and care. Stanford neighbors two Universities
of California (UC) at Berkeley, and at Davis, both elite research centers with a growing diabetes research base
unconnected to a NIDDK DRC. The SDRC is comprised of 124 members from 3 Schools at Stanford, and from
multiple Schools at UC Berkeley and UC Davis. SDRC members at Stanford currently have $65,044,250 in
annual direct costs for diabetes-related research. SDRC members are organized by affinity groups focused on
(i) Islet & Pancreas Biology, (ii) Metabolism & Signaling, (iii) Immunology, Transplantation & Stem Cell Biology,
and (iv) Bioengineering & Behavioral Sciences. The SDRC consists of: (1) Administrative Component that
coordinates scientific, organizational, enrichment, training and outreach activities, (2) Biomedical Research
Component that recruits and selects members, and supervises 4 Research Cores that facilitate and enhance
their research, and (3) a successful SDRC Pilot and Feasibility (P&F) Award Program that promotes the
diabetes research of early stage investigators, and established scientists new to diabetes research. We
propose to expand this Program to include a Regional P&F Program that supports research at UC Davis and
Berkeley. NIH support for the SDRC is amplified by (1) Stanford’s sustained commitment to provide space and
significant financial resources, (2) a comprehensive array of institutional research cores, which allow NIDDK
funds to support specialized SDRC research cores devoted to diabetes research, (3) collaborative efforts with
other Stanford research centers, and (4) SDRC member leadership of high-profile national diabetes research
efforts. Since P30 funding began in 2017, the SDRC has evolved, including growth of its investigator base,
intensified focus on translational research, and modification of...

## Key facts

- **NIH application ID:** 10668992
- **Project number:** 5P30DK116074-07
- **Recipient organization:** STANFORD UNIVERSITY
- **Principal Investigator:** Seung K Kim
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $1,967,401
- **Award type:** 5
- **Project period:** 2017-09-15 → 2027-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10668992

## Citation

> US National Institutes of Health, RePORTER application 10668992, Stanford Diabetes Research Center (5P30DK116074-07). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10668992. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*